Lovell D, Ruperto N, Giannini E, Martini A. Advances from clinical trials in juvenile idiopathic arthritis. Nat Rev Rheumatol. 2013;9:557–63.

Article  PubMed  Google Scholar 

Ruperto N, Martini A. Current and future perspectives in the management of juvenile idiopathic arthritis. Lancet Child Adolesc Heal. 2018;2(5):360–70.

Article  Google Scholar 

• Rosina S, Giancane G, Ruperto N. Emerging therapies for juvenile arthritis: agents in early clinical trials. Expert Opin Investig Drugs. 2022;31(10):1109–24. The work highlights the most recent therapeutic advances in the treatment of JIA.

Article  CAS  PubMed  Google Scholar 

Bernatsky S, Boivin J-F, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54(8):2550–7.

Article  CAS  PubMed  Google Scholar 

Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken). 2010;62(1):63–72.

Article  PubMed  Google Scholar 

Rider L, Lachenbruch P, Monroe J, Ravelli A, Cabalar I, Feldman B, et al. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum. 2009;60(11):3425–35.

Article  PubMed  PubMed Central  Google Scholar 

Sanner H, Kirkhus E, Merckoll E, Tollisen A, Røisland M, Lie B, et al. Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: a case-control study. Arthritis Care Res. 2010;62(8):1103–11.

Article  Google Scholar 

•• Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST, Becker ML, Cron RQ, Feldman BM, Ferguson PJ, Gewanter H, Guzman J, Kimura Y, Lee T, Murphy K, Nigrovic PA, Ombrello MJ, Rabinovich CE, Tesher M, Twilt M, Klein-Gitelman M, Barbar-Smiley F, Cooper AM, Edelheit B, Gillispie-Taylor M, Hays K, Mannion ML, Peterson R, Flanagan E, Saad N, Sullivan N, Szymanski AM, Trachtman R, Turgunbaev M, Veiga K, Turner AS, Reston JT. 2021 American College of Rheumatology Guideline for the treatment of juvenile idiopathic arthritis: recommendations for nonpharmacologic therapies, medication monitoring, immunizations, and imaging. Arthritis Care Res. 2022;74(4):505-520. American College of Rheumatology clinical practice guidelines for JIA on nonpharmacologic therapies, medication monitoring, immunizations, and imaging.

•• Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST, Becker ML, Cron RQ, Feldman BM, Ferguson PJ, Gewanter H, Guzman J, Kimura Y, Lee T, Murphy K, Nigrovic PA, Ombrello MJ, Rabinovich CE, Tesher M, Twilt M, Klein-Gitelman M, Barbar-Smiley F, Cooper AM, Edelheit B, Gillispie-Taylor M, Hays K, Mannion ML, Peterson R, Flanagan E, Saad N, Sullivan N, Szymanski AM, Trachtman R, Turgunbaev M, Veiga K, Turner AS, Reston JT. 2021 American College of Rheumatology Guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for oligoarthritis, temporomandibular joint arthritis, and systemic juvenile idiopathic arthritis. Arthritis Care Res. 2022;74(4):521-537. American College of Rheumatology clinical practice guidelines addressing the management of oligoarthritis, temporomandibular joint arthritis and systemic juvenile idiopathic arthritis.

Ringold S, Angeles-han ST, Beukelman T, Lovell D, Cuello C, Becker M, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis. Arthritis Care Res (Hoboken). 2019;71(6):717–34.

Article  PubMed  Google Scholar 

Groot N, De Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman B, et al. European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: The SHARE initiative. Ann Rheum Dis. 2017;76(10):1637–41.

Article  CAS  PubMed  Google Scholar 

Groot N, de Graeff N, Marks SSD, Brogan P, Avcin T, Bader-Meunier B, et al. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis. 2017;76(12):1965–73.

Article  CAS  PubMed  Google Scholar 

Enders FB, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, et al. Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis. 2017;76(2):329–40.

Article  Google Scholar 

Huber A, Robinson A, Reed A, Abramson L, Bout-Tabaku S, Carrasco R, et al. Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference. Arthritis Care Res (Hoboken). 2012;64(4):546–53.

Article  PubMed  Google Scholar 

Kim S, Kahn P, Robinson AB, Lang B, Shulman A, Oberle EJ, et al. Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease. Pediatr Rheumatol Online J. 2017;15(1):1.

Article  PubMed  PubMed Central  Google Scholar 

Huber AMA, Giannini E, Bowyer S, Kim S, Lang B, Lindsley C, et al. Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children’s Arthritis and Rheumatology Research Alliance Consensus Conference. Arthritis Care Res (Hoboken). 2010;62(2):219–25.

CAS  PubMed  Google Scholar 

Huber AM, Kim S, Reed AM, Carrasco R, Feldman BM, Hong SD, et al. Childhood arthritis and rheumatology research alliance consensus clinical treatment plans for juvenile dermatomyositis with persistent skin rash. J Rheumatol. 2017;44(1):110–6.

Article  CAS  PubMed  Google Scholar 

Ravelli A, Consolaro A, Horneff G, Laxer R, Lovell D, Wulffraat N, et al. Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2018;77(6):819–28.

PubMed  Google Scholar 

Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Ann Rheum Dis. 2011;70(9):1605–12.

Article  PubMed  Google Scholar 

Wallace C, Giannini E, Spalding S, Hashkes P, O’Neil K, Zeft A, et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum. 2012;64(6):2012–21.

Article  PubMed  Google Scholar 

Kim S, El-Hallak M, Dedeoglu F, Zurakowski D, Fuhlbrigge R, Sundel R. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment. Arthritis Rheum. 2009;60(6):1825–30.

Article  PubMed  PubMed Central  Google Scholar 

Bartoli M, Tarò M, Magni-Manzoni S, Pistorio A, Traverso F, Viola S, et al. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis. Ann Rheum Dis. 2008;67(3):370–4.

Article  CAS  PubMed  Google Scholar 

Oen K, Duffy CM, Tse SML, Ramsey S, Ellsworth J, Chédeville G, et al. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort. Arthritis Care Res (Hoboken). 2010;62(4):527–36.

Article  PubMed  Google Scholar 

• Giancane G, Rosina S, Consolaro A, Ruperto N. Outcome scores in pediatric rheumatology. Curr Rheumatol Rep. 2021;23(4):23. An updated description of the main outcome measures that are available for JIA, cSLE and JDM.

Article  PubMed  Google Scholar 

• Rosina S, Tibaldi J, Mazzoni M, Bava C, Natoli V, Ravelli A. Update on outcome measures for pediatric systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2020;72 Suppl 1:163–70. The paper offers a complete overview of the newest outcome scores specifically developed for use in children with cSLE.

Article  Google Scholar 

Rider L, Aggarwal R, Machado P, Hogrel J, Reed A, Christopher-Stine L, et al. Update on outcome assessment in myositis. Nat Rev Rheumatol. 2018;14(5):303–18.

Article  PubMed  PubMed Central  Google Scholar 

Berthold E, Månsson B, Kahn R. Outcome in juvenile idiopathic arthritis: a population-based study from Sweden. Arthritis Res Ther. 2019;21(1):218.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oen K, Guzman J, Dufault B, Tucker LB, Shiff NJ, Duffy KW, et al. Health-related quality of life in an inception cohort of children with juvenile idiopathic arthritis: a longitudinal analysis. Arthritis Care Res (Hoboken). 2018;70(1):134–44.

Article  PubMed  Google Scholar 

Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schöntube M, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46(9):2392–401.

Article  PubMed  Google Scholar 

Smolen JS. Treat to target in rheumatology: a historical account on occasion of the 10th anniversary. Rheum Dis Clin North Am. 2019;45(4):477–85.

Article  PubMed  Google Scholar 

Sokka T, Pincus T. Rheumatoid arthritis: strategy more important than agent. Lancet (London, England). 2009;374(9688):430–2.

Article  PubMed  Google Scholar 

Smolen J, Aletaha D, Bijlsma J, Breedveld F, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69(4):631–7.

Article  PubMed  Google Scholar 

Smolen J, Breedveld F, Burmester G, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3–15.

Article  PubMed  Google Scholar 

Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014;73(1):6–16.

Article  PubMed  Google Scholar 

Smolen JS, Schöls M, Braun J, Dougados M, FitzGerald O, Gladman DD, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. 2018;77(1):3–17.

Article  PubMed  Google Scholar 

van Vollenhoven R, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrøm K, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis. 2004;73(6):958–67.

Article  Google Scholar 

Kiltz U, Smolen J, Bardin T, Cohen Solal A, Dalbeth N, Doherty M, et al. Treat-to-target (T2T) recommendations for gout. Ann Rheum Dis. 2017;76(4):632–8.

Article  CAS  PubMed  Google Scholar 

Wollenhaupt J, Albrecht K, Krüger K, Müller-Ladner U. The new 2012 German recommendations for treating rheumatoid arthritis : differences compared to the European standpoint. Z Rheumatol. 2013;72(1):6–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–99.

Article  CAS